JT
RARE icon

Jupiter Topco’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jupiter Topco’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
+36,543
New +$908K ﹤0.01% 1716

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Jupiter Topco's RARE Position: Q2 2026 in Review

Jupiter Topco opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 36,543 shares worth $1.22M. The stake represents ﹤0.01% of the portfolio and ranks #1716 among its holdings.

287 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Jupiter Topco held 36,543 shares of Ultragenyx Pharmaceutical worth $1.22M as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new Jupiter Topco position in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1716 holding.
  • 287 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.